Skip to main content
Pavlos Msaouel, MD, Oncology, Houston, TX

PavlosMsaouelMDPhD

Oncology Houston, TX

Assistant Professor, Department of Genitourinary Medical Oncology

Dr. Msaouel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Msaouel's full profile

Already have an account?

  • Office

    1515 Holcombe Blvd
    Houston, TX 77030
    Phone+1 713-792-6161

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
  • Jacobi Medical Center/Albert Einstein College of Medicine
    Jacobi Medical Center/Albert Einstein College of MedicineChief Residency, Internal Medicine, 2014 - 2015
  • Jacobi Medical Center/Albert Einstein College of Medicine
    Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 2011 - 2014
  • University of Athens
    University of AthensClass of 2006

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2023 - 2026
  • TN State Medical License
    TN State Medical License 2023 - 2026
  • TX State Medical License
    TX State Medical License 2016 - 2026
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • LA State Medical License
    LA State Medical License 2023 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Publications & Presentations

PubMed

Lectures

  • Comparative transcriptomic profiling of renal medullary carcinoma (RMC) to determine distinct signatures and pathways associated with response to chemotherapy. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • KCA Brings Early-Career Clinicians Together for New Mentorship Program
    KCA Brings Early-Career Clinicians Together for New Mentorship ProgramNovember 14th, 2024
  • Targeted Combination Shows Promise in Metastatic Kidney Cancer
    Targeted Combination Shows Promise in Metastatic Kidney CancerNovember 13th, 2024
  • Renal Medullary Carcinoma: 5 Things to Know About This Rare and Aggressive Kidney Cancer
    Renal Medullary Carcinoma: 5 Things to Know About This Rare and Aggressive Kidney CancerSeptember 3rd, 2024
  • Join now to see all

Professional Memberships